Table 1. Expressions of FMNL3, E-Cadherin and Vimentin in clinical samples and associations with parameters.
Items | FMNL3 |
E-cadherin |
Vimentin |
||||||
---|---|---|---|---|---|---|---|---|---|
− | + ~ +++ | P value | − | + ~ +++ | P value | − | + ~ +++ | P value | |
Histological type | |||||||||
NPC | 39 | 80 | 0.000* | 76 | 43 | 0.000* | 37 | 82 | 0.000* |
NPG | 27 | 2 | 0 | 29 | 29 | 0 | |||
Age | |||||||||
<50 | 21 | 45 | 0.804 | 42 | 24 | 0.954 | 21 | 45 | 0.849 |
≥50 | 18 | 35 | 34 | 19 | 16 | 37 | |||
Gender | |||||||||
Male | 24 | 57 | 0.286 | 51 | 30 | 0.765 | 26 | 55 | 0.729 |
Female | 15 | 23 | 25 | 13 | 11 | 27 | |||
Smoking | |||||||||
Yes | 18 | 47 | 0.195 | 42 | 23 | 0.852 | 22 | 43 | 0.476 |
No | 21 | 33 | 34 | 20 | 15 | 39 | |||
Clinical classification | |||||||||
I-II | 13 | 4 | 0.000* | 4 | 13 | 0.000* | 11 | 6 | 0.001* |
III-IV | 26 | 76 | 72 | 30 | 26 | 76 | |||
T classification | |||||||||
T1-T2 | 23 | 26 | 0.006* | 25 | 24 | 0.015* | 21 | 28 | 0.020* |
T3-T4 | 16 | 54 | 51 | 19 | 16 | 54 | |||
N classification | |||||||||
N0-N1 | 19 | 23 | 0.032* | 23 | 19 | 0.127 | 16 | 26 | 0.223 |
N2-N3 | 20 | 57 | 53 | 24 | 21 | 56 | |||
M classification | |||||||||
M0 | 35 | 57 | 0.024* | 61 | 31 | 0.307 | 27 | 65 | 0.448 |
M1 | 4 | 23 | 15 | 12 | 10 | 17 |
NPG, nasopharyngitis; *significance as indicated.